PWA
WST icon

Principia Wealth Advisory’s West Pharmaceutical WST Stock Holding History

Principia Wealth Advisory’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59K Buy
10
+8
+400% +$2.45K ﹤0.01% 433
2026
Q1 		$501 Sell
2
-2
-50% -$498 ﹤0.01% 855
2025
Q4 		$1.1K Buy
4
+1
+33% +$274 ﹤0.01% 640
2025
Q3 		$787 Buy
3
+1
+50% +$243 ﹤0.01% 707
2025
Q2 		$438 Hold
2
– – ﹤0.01% 764
2025
Q1 		$407 Hold
2
– – ﹤0.01% 623
2024
Q4 		$655 Buy
+2
New +$629 ﹤0.01% 467

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Principia Wealth Advisory's WST Position: Q2 2026 in Review

Principia Wealth Advisory increased its West Pharmaceutical (WST) stake by 400% in Q2 2026, buying an estimated $2.45K and bringing the position to 10 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Principia Wealth Advisory first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Principia Wealth Advisory held 10 shares of West Pharmaceutical worth $3.59K as of Q2 2026.
  • Principia Wealth Advisory bought 8 West Pharmaceutical shares in Q2 2026, an estimated $2.45K.
  • West Pharmaceutical made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #433 holding.
  • Principia Wealth Advisory first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.